Pelvic Organ Prolapse
Total Payments
$403,646
Transactions
95
Doctors
3
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $403,646 | 95 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $403,646 | 95 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| XENFORM A/A POSTMARKET | Boston Scientific Corporation | $148,410 | 1 |
| UPHOLD LITE | Boston Scientific Corporation | $141,340 | 2 |
| SOLYX VS OBTRYX II STUDY | Boston Scientific Corporation | $56,395 | 0 |
| Permanent vs delayed absorbable monofilament suture | Boston Scientific Corporation | $50,001 | 0 |
| Post Operative Pain after Sacrospin | Boston Scientific Corporation | $7,500 | 0 |
Top Doctors Receiving Payments for Pelvic Organ Prolapse
Ad
Manufacturing Companies
- Boston Scientific Corporation $403,646
Product Information
- Type Device
- Total Payments $403,646
- Total Doctors 3
- Transactions 95
About Pelvic Organ Prolapse
Pelvic Organ Prolapse is a device associated with $403,646 in payments to 3 healthcare providers, recorded across 95 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2017 to 2017. In 2017, $403,646 was paid across 95 transactions to 3 doctors.
The most common payment nature for Pelvic Organ Prolapse is "Unspecified" ($403,646, 100.0% of total).
Pelvic Organ Prolapse is associated with 5 research studies, including "XENFORM A/A POSTMARKET" ($148,410).